Published in

BioMed Central, Experimental Hematology and Oncology, 1(8), 2019

DOI: 10.1186/s40164-019-0141-1

Links

Tools

Export citation

Search in Google Scholar

Ibrutinib inhibits antibody dependent cellular cytotoxicity induced by rituximab or obinutuzumab in MCL cell lines, not overcome by addition of lenalidomide

Journal article published in 2019 by Alexandra Albertsson-Lindblad ORCID, Catja Freiburghaus, Mats Jerkeman, Sara Ek ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO